As there is no clear biomarker to diagnose Parkinson’s disease,
this meta-analysis aims to comprehensively evaluates the correlation between serum
Cystatin C levels and Parkinson’s disease in the Chinese population by the meta-analysis method. PubMed, Web of Science, Embase, Cochrane Library, China national
knowledge infrastructure, and China WanFang databases were systematically
searched on the correlation between serum Cystatin C
and Parkinson’s disease. The results showed that Cystatin C level in Parkinson’s disease patients compared
with the control group, the standardized mean difference = 1.78 (95%
CI: 1.33~2.24, P
Cite this article
54
Downloads
2
Citations
228
Views
Announcements
Open Access
Short Communication
On the correlation between serum Cystatin C and Parkinson’s disease in the Chinese population: a promising biomarker?
Show Less
1
Bagualing Community Health Service Centre, The Eighth Affiliated Hospital, SUN YAT-SEN University, 518033 Shenzhen, Guangdong, China
2
Department of Rehabilitation Medicine, The Eighth Affiliated Hospital, SUN YAT-SEN University, 518033 Shenzhen, Guangdong, China
*Correspondence: yangchanggui987@126.com (Chang-Gui Yang)
J. Integr. Neurosci. 2021, 20(2), 349–357;
https://doi.org/10.31083/j.jin2002034
Submitted: 7 December 2020 | Revised: 12 January 2021 | Accepted: 23 February 2021 | Published: 30 June 2021
Copyright: © 2021 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Abstract
Keywords
Cystatin C
Parkinson's disease
Meta-analysis
Mild cognitive impairment
Figures
Fig. 1.